Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial coiled-coil domain protein 1 (MCCD1) is a nuclear-encoded mitochondrial protein characterized by a coiled-coil domain and is located at the telomeric end of the major histocompatibility complex (MHC) class III region in humans[3][6][9]. MCCD1 is widely expressed in various tissues and is primarily localized within mitochondria[5][6][8]. Its precise physiological function remains unclear; however, related members in the coiled-coil-helix-coiled-coil-helix (CHCH) domain family are known to contribute to the structural integrity and stabilization of mitochondrial protein complexes[7]. There are no known roles for MCCD1 as a drug target, nor are there any known diseases directly associated with its mutation or dysregulation.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial coiled-coil domain protein 1 (MCCD1).